Co-Authors
This is a "connection" page, showing publications co-authored by Carlos Macaya and Sergio Raposeiras-Roubín.
Connection Strength
0.919
-
Underlying heart diseases and acute COVID-19 outcomes. Cardiol J. 2021; 28(2):202-214.
Score: 0.230
-
Health Outcome Predictive Evaluation for COVID 19 international registry (HOPE COVID-19), rationale and design. Contemp Clin Trials Commun. 2020 Dec; 20:100654.
Score: 0.226
-
Impact of smoking on COVID-19 outcomes: a HOPE Registry subanalysis. BMJ Nutr Prev Health. 2021; 4(1):285-292.
Score: 0.059
-
Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry. Am Heart J. 2021 07; 237:104-115.
Score: 0.059
-
[Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry]. Rev Esp Cardiol. 2021 Jul; 74(7):608-615.
Score: 0.058
-
Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19. Age Ageing. 2021 02 26; 50(2):326-334.
Score: 0.058
-
Clinical presentation, therapeutic approach, and outcome of young patients admitted for COVID-19, with respect to the elderly counterpart. Clin Exp Med. 2021 May; 21(2):249-268.
Score: 0.058
-
Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry. Rev Esp Cardiol (Engl Ed). 2021 Jul; 74(7):608-615.
Score: 0.058
-
Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry. Intern Emerg Med. 2021 06; 16(4):957-966.
Score: 0.057
-
Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry. J Nephrol. 2020 08; 33(4):737-745.
Score: 0.056